{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:34:02Z","timestamp":1789842842321,"version":"4.0.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aaceclinicalcasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Clinical Case Reports"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.aace.2024.10.005","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T06:54:03Z","timestamp":1729666443000},"page":"53-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Case of Severe Cushing Syndrome due to Metastatic Adrenocortical Carcinoma Treated With Osilodrostat"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5721-1874","authenticated-orcid":false,"given":"Kathleen R.","family":"Ruddiman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine E.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander K.","family":"Bonnecaze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.aace.2024.10.005_bib1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"issue":"9","key":"10.1016\/j.aace.2024.10.005_bib2","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.eprac.2021.06.012","article-title":"Osilodrostat: a review of recent clinical studies and practical recommendations for its use in the treatment of Cushing disease","volume":"27","author":"Yuen","year":"2021","journal-title":"Endocr Pract"},{"issue":"11","key":"10.1016\/j.aace.2024.10.005_bib3","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.4158\/DSCR-2020-0567","article-title":"American Association of Clinical Endocrinology Disease State Clinical Review on the evaluation and management of adrenocortical carcinoma in an adult: a practical approach","volume":"26","author":"Kiseljak-Vassiliades","year":"2020","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.aace.2024.10.005_bib4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.surg.2018.04.068","article-title":"Longitudinal patterns of recurrence in patients with adrenocortical carcinoma","volume":"165","author":"Glenn","year":"2019","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.aace.2024.10.005_bib5","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1210\/jc.2016-2894","article-title":"Long-term outcomes of adjuvant mitotane therapy in patients with radically resected adrenocortical carcinoma","volume":"102","author":"Berruti","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.aace.2024.10.005_bib6","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jamcollsurg.2015.12.013","article-title":"Outcomes of adjuvant mitotane after resection of adrenocortical carcinoma: a 13-institution study by the US Adrenocortical Carcinoma Group","volume":"222","author":"Postlewait","year":"2016","journal-title":"J\u00a0Am Coll Surg"},{"issue":"Supplement_1","key":"10.1016\/j.aace.2024.10.005_bib7","doi-asserted-by":"crossref","first-page":"A166","DOI":"10.1210\/jendso\/bvab048.336","article-title":"Results of the ADIUVO study, the first randomized trial on adjuvant mitotane in adrenocortical carcinoma patients","volume":"5","author":"Terzolo","year":"2021","journal-title":"J\u00a0Endocr Soc"},{"issue":"6","key":"10.1016\/j.aace.2024.10.005_bib8","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1210\/endrev\/bnac012","article-title":"Update on biology and genomics of adrenocortical carcinomas: rationale for emerging therapies","volume":"43","author":"Lerario","year":"2022","journal-title":"Endocr Rev"},{"issue":"9","key":"10.1016\/j.aace.2024.10.005_bib9","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S2213-8587(20)30240-0","article-title":"Efficacy and safety of osilodrostat in patients with Cushing\u2019s disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase","volume":"8","author":"Pivonello","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1016\/j.aace.2024.10.005_bib11","doi-asserted-by":"crossref","first-page":"L7","DOI":"10.1530\/EJE-20-0557","article-title":"Efficacy and tolerance of osilodrostat in patients with severe Cushing\u2019s syndrome due to non-pituitary cancers","volume":"183","author":"Haissaguerre","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.aace.2024.10.005_bib12","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1530\/EJE-21-1008","article-title":"Efficacy and tolerance of osilodrostat in patients with Cushing\u2019s syndrome due to adrenocortical carcinomas","volume":"186","author":"Tabarin","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.aace.2024.10.005_bib13","first-page":"124","article-title":"Cushing\u2019s syndrome in adenocarcinoma of lung responding to osilodrostat","volume":"16","author":"Heleno","year":"2023","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.aace.2024.10.005_bib14","doi-asserted-by":"crossref","DOI":"10.1530\/EDM-21-0071","article-title":"Synergistic cortisol suppression by ketoconazole\u2013osilodrostat combination therapy","author":"Amodru","year":"2021","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"1","key":"10.1016\/j.aace.2024.10.005_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ando.2021.11.007","article-title":"Pembrolizumab-induced cyclic ACTH-dependent Cushing\u2019s syndrome treated by a block-and-replace approach with osilodrostat","volume":"83","author":"Paepegaey","year":"2022","journal-title":"Ann Endocrinol"},{"issue":"6","key":"10.1016\/j.aace.2024.10.005_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.aace.2022.10.001","article-title":"Adrenal Cushing\u2019s syndrome treated with preoperative osilodrostat and adrenalectomy","volume":"8","author":"Malik","year":"2022","journal-title":"AACE Clin Case Rep"},{"issue":"4","key":"10.1016\/j.aace.2024.10.005_bib17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s42000-022-00397-4","article-title":"Cushing\u2019s syndrome: a combined treatment with etomidate and osilodrostat in severe life-threatening hypercortisolemia","volume":"21","author":"Dzialach","year":"2022","journal-title":"Hormones (Athens)"},{"issue":"5","key":"10.1016\/j.aace.2024.10.005_bib18","doi-asserted-by":"crossref","first-page":"L13","DOI":"10.1530\/EJE-21-0147","article-title":"Rapid control of severe ectopic Cushing\u2019s syndrome by oral osilodrostat monotherapy","volume":"184","author":"Bessi\u00e8ne","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.aace.2024.10.005_bib19","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1210\/clinem\/dgac691","article-title":"Efficacy and safety of osilodrostat in paraneoplastic Cushing syndrome: a real-world multicenter study in France","volume":"108","author":"Dormoy","year":"2023","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.aace.2024.10.005_bib20","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1507\/endocrj.EJ19-0617","article-title":"A\u00a0multicenter, phase 2 study to evaluate the efficacy and safety of osilodrostat, a new 11\u03b2-hydroxylase inhibitor, in Japanese patients with endogenous Cushing\u2019s syndrome other than Cushing\u2019s disease","volume":"67","author":"Tanaka","year":"2020","journal-title":"Endocr J"}],"container-title":["AACE Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060524001147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060524001147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:30:08Z","timestamp":1736814608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2376060524001147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2376060524001147"],"URL":"https:\/\/doi.org\/10.1016\/j.aace.2024.10.005","relation":{},"ISSN":["2376-0605"],"issn-type":[{"value":"2376-0605","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Case of Severe Cushing Syndrome due to Metastatic Adrenocortical Carcinoma Treated With Osilodrostat","name":"articletitle","label":"Article Title"},{"value":"AACE Clinical Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aace.2024.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}